GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GS...
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014.
On Thursday, GSK said Tesaro has filed a ...